BNTX
Price
$101.44
Change
-$1.09 (-1.06%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
24.65B
111 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$64.92
Change
+$0.61 (+0.95%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
4.67B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BNTX vs KYMR

Header iconBNTX vs KYMR Comparison
Open Charts BNTX vs KYMRBanner chart's image
BioNTech SE American Depositary Share
Price$101.44
Change-$1.09 (-1.06%)
Volume$8.87K
Capitalization24.65B
Kymera Therapeutics
Price$64.92
Change+$0.61 (+0.95%)
Volume$10.2K
Capitalization4.67B
BNTX vs KYMR Comparison Chart in %
BNTX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BNTX vs. KYMR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BNTX: $102.53 vs. KYMR: $64.38)
Brand notoriety: BNTX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 110% vs. KYMR: 48%
Market capitalization -- BNTX: $24.39B vs. KYMR: $4.67B
BNTX [@Biotechnology] is valued at $24.39B. KYMR’s [@Biotechnology] market capitalization is $4.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • BNTX’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а -5.63% price change this week, while KYMR (@Biotechnology) price change was +1.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

BNTX is expected to report earnings on Mar 10, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($24.7B) has a higher market cap than KYMR($4.67B). KYMR YTD gains are higher at: 60.017 vs. BNTX (-10.022). BNTX has higher annual earnings (EBITDA): -72.1M vs. KYMR (-267.03M). BNTX has more cash in the bank: 14B vs. KYMR (665M). KYMR has less debt than BNTX: KYMR (85.7M) vs BNTX (270M). BNTX has higher revenues than KYMR: BNTX (2.88B) vs KYMR (44.7M).
BNTXKYMRBNTX / KYMR
Capitalization24.7B4.67B529%
EBITDA-72.1M-267.03M27%
Gain YTD-10.02260.017-17%
P/E Ratio161.76N/A-
Revenue2.88B44.7M6,438%
Total Cash14B665M2,105%
Total Debt270M85.7M315%
FUNDAMENTALS RATINGS
BNTX: Fundamental Ratings
BNTX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
72%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KEAT29.870.16
+0.54%
Keating Active ETF
UITB47.460.05
+0.11%
VictoryShares Core Intermediate Bond ETF
SUPP69.66N/A
N/A
TCW Transform Supply Chain ETF
EGGS39.89-0.09
-0.22%
NestYield Total Return Guard ETF
EEMS67.73-0.46
-0.68%
iShares MSCI Emerging Markets Sm-Cp ETF

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-0.14%
MRNA - BNTX
56%
Loosely correlated
+0.65%
SMMT - BNTX
51%
Loosely correlated
-0.88%
KYMR - BNTX
48%
Loosely correlated
+0.43%
TIL - BNTX
45%
Loosely correlated
+1.80%
NVAX - BNTX
44%
Loosely correlated
-3.38%
More